On September 8th, the Ministry of Commerce, the National Health Commission, and the National Medical Products Administration issued a notice on expanding the pilot work of opening up in the medical field, involving two major areas: biotechnology and wholly-owned hospitals. In Beijing, Shanghai, Guangdong Free Trade Zone, and Hainan Free Trade Port, foreign-invested enterprises are allowed to engage in the development and application of human stem cell, gene diagnosis, and treatment technologies for product registration, listing, and production.
Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114